TipRanks
Go Ultimate55% OFF

Compare HLS Therapeutics Inc (74D) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:74DHLS Therapeutics IncEUR 2.78EUR 89.09M-12.23-14.72%Moderate BuyDE:74D
TSE:GUDKnight TherapeuticsCAD 11.27CAD 1.11B76.6194.31%Strong BuyDE:74D vs TSE:GUD
TSE:CPHCipher PharmaceuticalsCAD 13.05CAD 331.67M8.19-8.87%Moderate BuyDE:74D vs TSE:CPH
TSE:AQSAequus PharmaceuticalsCAD 0.01CAD 663.17K3.130.00%―DE:74D vs TSE:AQS
TSE:MDPMedexus Pharmaceuticals IncCAD 4.93CAD 154.93M-46.2474.82%Moderate BuyDE:74D vs TSE:MDP
TSE:RXBiosyentCAD 17.09CAD 193.27M19.4258.24%Moderate BuyDE:74D vs TSE:RX

Performance Comparison

-50%-25%0%25%50%75%100%125%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:74DHLS Therapeutics Inc2.78-0.48-14.72%
TSE:GUDKnight Therapeutics11.275.4392.98%
TSE:CPHCipher Pharmaceuticals13.05-1.69-11.47%
TSE:AQSAequus Pharmaceuticals0.010.000.00%
TSE:MDPMedexus Pharmaceuticals Inc4.932.1376.07%
TSE:RXBiosyent17.096.3058.46%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts